Pleco Therapeutics
Clinical stage biopharmaceutical company
Pleco Therapeutics has raised €17M across 1 funding round from 3 investors, most recently a Series A round in Sep 2022. Based in Nijmegen, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Nijmegen, Netherlandswww.plecotherapeutics.com ↗
Total raised
€17M
€17,300,000
Funding rounds
1
Investors
3
distinct backers
Active since
2022-09
latest 2022-09
Funding by year
EUR raised per yearPleco Therapeutics — funding by year — interactive chart.
Data table
| Pleco Therapeutics — funding by year | |
|---|---|
| 2022 | €17M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-07 | Series A | €17M | Hyloris Pharmaceuticals,Netherlands Enterprise Agency,Oost NL | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData